Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001367810 | SCV001564176 | uncertain significance | not provided | 2022-05-25 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with SLC34A1-related conditions. This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 473 of the SLC34A1 protein (p.Ile473Thr). This variant is present in population databases (rs184668287, gnomAD 0.01%). ClinVar contains an entry for this variant (Variation ID: 1058648). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002488141 | SCV002803868 | uncertain significance | Hypophosphatemic nephrolithiasis/osteoporosis 1; Fanconi renotubular syndrome 2; Hypercalcemia, infantile, 2 | 2024-05-17 | criteria provided, single submitter | clinical testing |